Evidence map›Paper›PMID 19375390›Full record

ArticleClinical immunology (Orlando, Fla.)2009

Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome.

Laurence E Cheng, Bittoo Kanwar, Haig Tcheurekdjian, James P Grenert, Mica Muskat, Melvin B Heyman, Joseph M McCune, Diane W Wara

Abstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Recent Advance in Very Early Onset Inflammatory Bowel Disease.Pediatric gastroenterology, hepatology & nutrition · 2019
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Novel Mutations of theFrontiers in immunology · 2017
    Article
  17. Article
  18. Article
  19. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laurence E ChengDepartment of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA 94143, USA. ChengL@peds.ucsf.edu
Bittoo Kanwar
Haig Tcheurekdjian
James P Grenert
Mica Muskat
Melvin B Heyman
Joseph M McCune
Diane W Wara

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
TRAINING PROGRAM IN PEDIATRIC GASTROENTEROLOGY/NUTRITIONT32DK007762 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI James Bayrer · 1998 to 2026
$7.3M
NIH Director's Pioneer Award (RMI)DP1OD000329 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2004 to 2008
$4.2M
NICHD Institutional Training for PediatriciansT32HD044331 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIERO, DONNA M. · 2003 to 2012
$2.5M
Studies in Children with Digestive DisordersK24DK060617 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HEYMAN, MELVIN B. · 2002 to 2011
$1.6M
NCRR NIH HHS UL1 RR024131NICHD NIH HHS T32 HD044331NIDDK NIH HHS K24 DK060617NIDDK NIH HHS T32 DK007762NIH HHS DP1 OD000329NIH HHS OD00329
6 · The paper itself

Abstract

The NEMO syndrome is a primary immunodeficiency with immune and non-immune manifestations. The immune deficiency is heterogeneous showing defects in humoral, innate, and cell-mediated immunity. While the clinical aspects of the immunodeficiency are increasingly well understood, little is known about autoimmune manifestations in NEMO patients. We therefore sought to examine serologic markers of systemic inflammation and intestinal pathology in a kindred of patients with the NEMO syndrome. We observed persistent elevation of erythrocyte sedimentation rates in five patients, and two were symptomatic, with a chronic but atypical enterocolitis. Though pathologic lesions in these two patients were consistent with acute inflammation, sustained clinical improvement was only achieved with systemic and/or topical glucocorticoid therapy. Our data suggest that some patients with the NEMO syndrome exhibit persistent elevation of inflammatory markers similar to systemic autoimmune diseases and may subsequently develop an atypical enterocolitis.

Indexed as

AdolescentBlood SedimentationChildChild, PreschoolColonoscopyEnterocolitisFemaleHumansImmunologic Deficiency SyndromesInfantInflammationMalePedigree

Identifiers

PMID19375390
PMCPMC2800791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.